Abstract
The United States has become preoccupied with the threat of bioterrorism — the potential for the poisoning of the milk supply with botulinum toxin, the hypothetical dissemination of smallpox by self-infected terrorists, the possibility of a massive release of aerosolized anthrax spores in the subway, even the newly raised specter of misuse of a reconstructed 1918 influenza virus. These concerns have had important consequences for the biomedical research agenda, funding priorities, and the regulatory environment.

This publication has 5 references indexed in Scilit: